A Prospective Study on Assessment of Quality of Life and Complications Related to Diabetic Patients in South India Communities

Purpose: This study's objective was to have a thorough grasp of patient profiles, Quality of life and related risk factors in individuals with diabetes, to improve clinical pharmacy services and diabetes management. Methodology: The study recruited 107 diabetes participants, collecting data through surveys, interviews, medication histories, and laboratory results. Patients with type 1 or type 2 diabetes who were above 18 and had been exposed to diabetes for more than two years met the inclusion criteria. The Pranav Diabetes Center Ethics Committee gave their approval to the project, which was conducted as a prospective, cross-sectional study from November 24, 2023, to January 17, 2024, in Bangalore. Data were analysed using SPSS version 26, employing multivariate logistical regression and a modified WHOQOL-BREF questionnaire. Results: The study included 107 participants (52 males, 55 females). Most were over 46, married, urban residents, non-smokers, and non-drinkers. 62% were non-working. Blood sugar levels varied, showing diverse glycemic control. Metformin was the most prescribed medication (61.4%), followed by insulin (9.8%). Diabetes affected work efficiency, physical health, and personal relationship satisfaction. Conclusion: The study highlights the diverse profiles and challenges faced by diabetic patients. Regular monitoring and tailored medication regimens are essential for effective management. An improving understanding of patient-specific factors can enhance care and outcomes. Major Contribution to the Field: This research provides important new understandings of the clinical and demographic characteristics of patients with diabetes, emphasizing the need for individualized care approaches and regular monitoring to improve diabetes management and patient Quality of life.